Articles

Poll

Podcasts

Slideshows

Videos

Cardiology

Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

Study presented at ISC 2024 suggests Black women with hypertension before age 35 face a 3-fold increase in risk of stroke while hypertension before 45 linked to doubling in stroke risk.

Hypertension Before 40 Linked to Doubling of Stroke Risk in Black Women

On January 25, 2024, the day following the proposed PDUFA goal date, Liquidia Corporation announced the FDA was still reviewing the NDA for pulmonary hypertension with interstitial lung disease for treprostinil inhalation powder (Yutrepia).

Liquidia Corporation: FDA Still Reviewing NDA to Add PH-ILD Indication for Treprostinil Inhalation Powder

A new study is raising awareness around the effects of structural racism on the prevalence of chronic health conditions. 

Structural Racism Linked to Increased Prevalence of Kidney Disease, Diabetes, & Cardiovascular Disease

The FDA has approved the second renal denervation device in the agency's history with the approval of Medtronic's Symplicity Spyral system. 

FDA Approves Medtronic's Symplicity Spyral Renal Denervation System

Lowering blood pressure significantly reduced the risk of developing dementia among adults with hypertension in China compared to usual care.

Blood Pressure Intervention Reduces Dementia Risk in People with Hypertension 

The phase 2 KARDIA-1 study reports a single dose of zilebesiran safely reduced systolic blood pressure in people with mild-to-moderate hypertension for up to  6 months.

Zilebesiran Effectively Lowers Blood Pressure in Patients with Uncontrolled Hypertension 

On November 7, 2023, Recor Medical announced the FDA approval of their Paradise Ultrasound Renal Denervation system for the treatment of hypertension. 

FDA Approves Recor Medical's Paradise Ultrasound Renal Denervation System

Richard Johnson, MD, discusses the results of a study from ASN Kidney Week 2023 detailing the effects of urate-lowering therapy on blood pressure among patients with gout. 

Pegloticase Plus Methotrexate Shows Hypertension Benefit in Gout Patients, with Richard Johnson, MD

An analysis of Target-HTN provides new insight into the effects of lorundrostat among patients with uncontrolled or treatment-resistant hypertension. 

Analysis Suggests Benefits of Lorundrostat Most Apparent with Elevated BMI, Baseline Blood Pressure

An analysis of more than 1 million men found higher blood pressure in late adolescence was associated with an increased risk for major cardiovascular events in later life. 

High Blood Pressure in Adolescence Increases Cardiovascular Event Risk, Study Finds

The HCPLive hypertension page is a resource for medical news and expert insights on high blood pressure. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for hypertension, and more.